Hydrochlorothiazide Tablet
Product Images NDC 71205-751

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 71205-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hctz Structural Formula (Image 1)

Hctz Structural Formula (Image 1)
Chemical structure diagram of Hydrochlorothiazide showing a bicyclic ring system with sulfonamide and chlorine substituents.*
FDA Label Image

71205-751-90 (Image 3)

71205-751-90 (Image 3)
Label for Hydrochlorothiazide 50 mg tablets, with a quantity of 90 tablets. The label indicates the product is labeled by Proficient Rx LP and manufactured by Teva Czech Industries s.r.o. in the Czech Republic. It features instructions on storage temperature and detailed tablet description, including identification markings and physical characteristics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.